569 results on '"Cosentino, Nicola"'
Search Results
2. Performance comparison of 6 in-hospital patient monitoring systems in the detection and alarm of ventricular cardiac arrhythmias
3. Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction
4. Whole-Blood Transcriptome Unveils Altered Immune Response in Acute Myocardial Infarction Patients With Aortic Valve Sclerosis
5. Hemostatic system in Takotsubo patients at long-term follow-up: A hidden activation?
6. Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12 and Link to Residual Platelet Reactivity
7. Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function
8. The Impact of COVID-19 Pandemic on Scientific Research: an Upcoming New Wave?
9. Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction
10. Diabetes Mellitus and Acute Myocardial Infarction: Impact on Short and Long-Term Mortality
11. Reply to: The Impact of COVID-19 Pandemic on Scientific Research: an Upcoming New Wave?
12. Abstract 11522: Impact of Chronic Glucagon-Like Peptide-1 Receptor Agonist and Sodium Glucose Cotransporter-2 Inhibitor Therapy on In-Hospital Outcomes of Patients Hospitalized With Acute Myocardial Infarction
13. Persistent long-term platelet activation and endothelial perturbation in women with Takotsubo syndrome
14. Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients
15. Chapter Three - Vitamin D and cardiovascular diseases.
16. Whole-Blood Transcriptome Unveils Altered Immune Response in Acute Myocardial Infarction Patients With Aortic Valve Sclerosis
17. Fluid balance in heart failure
18. Prognostic Impact of Percutaneous Coronary Intervention in Older Patients Hospitalized with Acute Myocardial Infarction: Real-World Findings from the Lombardy Health Database
19. Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y 12 and Link to Residual Platelet Reactivity
20. Intracranial haemorrhage in acute myocardial infarction: A rare but dramatic complication
21. Diabetes Mellitus and Acute Myocardial Infarction: Impact on Short and Long-Term Mortality
22. Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus
23. Glomerular filtration rate estimation and all-cause and cardiovascular mortality risk prediction: a progressive refinement in accuracy
24. Aortic valve sclerosis in patients with acute myocardial infarction: a marker of increased risk of re-infarction
25. Prognostic Impact of Percutaneous Coronary Intervention in Chronic Dialysis Patients with Acute Myocardial Infarction: Findings from the Lombardy Health Database
26. Peri-angiography Hemofiltration to Reduce Mortality
27. Renal replacement therapy in patients with acute myocardial infarction: Rate of use, clinical predictors and relationship with in-hospital mortality
28. Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12 and Link to Residual Platelet Reactivity.
29. Effect of hemorheological parameters on myocardial injury after primary or elective percutaneous coronary intervention
30. PROGNOSTIC IMPACT OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS HOSPITALIZED WITH ACUTE MYOCARDIAL INFARCTION OLDER THAN 90 YEARS
31. PROGNOSTIC IMPACT OF PERCUTANEOUS CORONARY INTERVENTION IN ACUTE MYOCARDIAL INFARCTION PATIENTS OLDER THAN 75 YEARS. REAL-WORLD FINDINGS FROM THE LOMBARDY HEALTH DATABASE.
32. Head-to-head comparison of four COVID-19 vaccines on platelet activation, coagulation and inflammation. The TREASURE study
33. TEMPORAL TRENDS (2003-2018) OF IN-HOSPITAL AND 30-DAY POST-DISCHARGE MORTALITY IN PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE. REAL-WORLD FINDINGS FROM THE LOMBARDY HEALTH DATABASES.
34. Hemostatic System in Takotsubo Patients at Long-Term Follow-Up: A Hidden Activation?
35. B-type natriuretic peptide levels in patients with pericardial effusion undergoing pericardiocentesis
36. Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease
37. Myocardial Infarct Size in Patients on Long-Term Statin Therapy Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
38. Biological profile of monocyte-derived macrophages in coronary heart disease patients: implications for plaque morphology
39. A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes
40. 1056 AN OUT OF ORDINARY CASE OF ACUTE SEVERE AORTIC REGURGITATION IN SPONTANEOUS AORTIC VALVE LACERATION
41. Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial
42. Outcomes and mechanical complications of acute myocardial infarction during the second wave pandemic in a Milan HUB center for cardiac emergencies
43. Inflammation and left ventricular thrombosis after STEMI: Risk marker or risk factor?
44. Impact of Prior Statin Therapy on In-Hospital Outcome of STEMI Patients Treated with Primary Percutaneous Coronary Intervention
45. Impact of Accuracy of Fractional Flow Reserve to Reduction of Microvascular Resistance After Intracoronary Adenosine in Patients With Angina Pectoris or Non–ST-Segment Elevation Myocardial Infarction
46. Abstract 20106: Prognostic Value of the Acute to Chronic Glycemic Ratio at Admission in Acute Myocardial Infarction
47. Prognostic Stratification of Patients With ST-Segment–Elevation Myocardial Infarction (PROSPECT): A Cardiac Magnetic Resonance Study
48. Case-Control Registry of Excimer Laser Coronary Angioplasty Versus Distal Protection Devices in Patients With Acute Coronary Syndromes due to Saphenous Vein Graft Disease
49. Open-Label, Randomized, Placebo-Controlled Evaluation of Intracoronary Adenosine or Nitroprusside After Thrombus Aspiration During Primary Percutaneous Coronary Intervention for the Prevention of Microvascular Obstruction in Acute Myocardial Infarction: The REOPEN-AMI Study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction)
50. Additional file 1 of Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.